Cargando…
Clinical Utility of Bronchoalveolar Lavage Neutrophilia and Biomarkers for Evaluating Severity of Chronic Fibrosing Interstitial Lung Diseases
Introduction It is hypothesized that bronchoalveolar lavage (BAL) neutrophilia, Krebs von den Lungen-6 (KL-6), and C-reactive protein (CRP) predict the severity of chronic fibrosing interstitial lung diseases (CF-ILDs). Methods This cross-sectional study enrolled 30 CF-ILD patients. Using Pearson’s...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439013/ https://www.ncbi.nlm.nih.gov/pubmed/37602059 http://dx.doi.org/10.7759/cureus.42162 |
_version_ | 1785092845256835072 |
---|---|
author | Shadrach, Benhur Joel Dutt, Naveen Elhence, Poonam Banerjee, Mithu Chauhan, Nishant Kumar Jalandra, Ram N Garg, Mahendra Kumar Garg, Pawan Tandon, Abhishek Shishir, Saumya Kochar, Rishabh Chhatwani, Bhavesh Pareek, Piyush Parrikar, Anika |
author_facet | Shadrach, Benhur Joel Dutt, Naveen Elhence, Poonam Banerjee, Mithu Chauhan, Nishant Kumar Jalandra, Ram N Garg, Mahendra Kumar Garg, Pawan Tandon, Abhishek Shishir, Saumya Kochar, Rishabh Chhatwani, Bhavesh Pareek, Piyush Parrikar, Anika |
author_sort | Shadrach, Benhur Joel |
collection | PubMed |
description | Introduction It is hypothesized that bronchoalveolar lavage (BAL) neutrophilia, Krebs von den Lungen-6 (KL-6), and C-reactive protein (CRP) predict the severity of chronic fibrosing interstitial lung diseases (CF-ILDs). Methods This cross-sectional study enrolled 30 CF-ILD patients. Using Pearson’s correlation analysis, BAL neutrophils, KL-6, and CRP were correlated with forced vital capacity (FVC), diffusing lung capacity for carbon monoxide (DLCO), six-minute walk distance (6MWD), partial pressure of oxygen (PaO2), computed tomography fibrosis score (CTFS), and pulmonary artery systolic pressure (PASP). Using the receiver operator characteristic (ROC) curve, BAL KL-6 and CRP were evaluated against FVC% and DLCO% in isolation and combination with BAL neutrophilia for predicting the severity of CF-ILDs. Results BAL neutrophilia significantly correlated only with FVC% (r = -0.38, P = 0.04) and DLCO% (r = -0.43, P = 0.03). BAL KL-6 showed a good correlation with FVC% (r = -0.44, P < 0.05) and DLCO% (r = -0.50, P = 0.02), while BAL CRP poorly correlated with all parameters (r = 0.0-0.2). Subset analysis of BAL CRP in patients with CTFS ≤ 15 showed a better association with FVC% (r = -0.28, P = 0.05) and DLCO% (r = -0.36, P = 0.04). BAL KL-6 cut-off ≥ 72.32 U/ml and BAL CRP ≥ 14.55 mg/L predicted severe disease with area under the curve (AUC) values of 0.77 and 0.71, respectively. The combination of BAL neutrophilia, KL-6, and CRP predicted severity with an AUC value of 0.89. Conclusion The combination of BAL neutrophilia, KL-6, and CRP facilitates the severity stratification of CF-ILDs complementing existing severity parameters. |
format | Online Article Text |
id | pubmed-10439013 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-104390132023-08-20 Clinical Utility of Bronchoalveolar Lavage Neutrophilia and Biomarkers for Evaluating Severity of Chronic Fibrosing Interstitial Lung Diseases Shadrach, Benhur Joel Dutt, Naveen Elhence, Poonam Banerjee, Mithu Chauhan, Nishant Kumar Jalandra, Ram N Garg, Mahendra Kumar Garg, Pawan Tandon, Abhishek Shishir, Saumya Kochar, Rishabh Chhatwani, Bhavesh Pareek, Piyush Parrikar, Anika Cureus Pulmonology Introduction It is hypothesized that bronchoalveolar lavage (BAL) neutrophilia, Krebs von den Lungen-6 (KL-6), and C-reactive protein (CRP) predict the severity of chronic fibrosing interstitial lung diseases (CF-ILDs). Methods This cross-sectional study enrolled 30 CF-ILD patients. Using Pearson’s correlation analysis, BAL neutrophils, KL-6, and CRP were correlated with forced vital capacity (FVC), diffusing lung capacity for carbon monoxide (DLCO), six-minute walk distance (6MWD), partial pressure of oxygen (PaO2), computed tomography fibrosis score (CTFS), and pulmonary artery systolic pressure (PASP). Using the receiver operator characteristic (ROC) curve, BAL KL-6 and CRP were evaluated against FVC% and DLCO% in isolation and combination with BAL neutrophilia for predicting the severity of CF-ILDs. Results BAL neutrophilia significantly correlated only with FVC% (r = -0.38, P = 0.04) and DLCO% (r = -0.43, P = 0.03). BAL KL-6 showed a good correlation with FVC% (r = -0.44, P < 0.05) and DLCO% (r = -0.50, P = 0.02), while BAL CRP poorly correlated with all parameters (r = 0.0-0.2). Subset analysis of BAL CRP in patients with CTFS ≤ 15 showed a better association with FVC% (r = -0.28, P = 0.05) and DLCO% (r = -0.36, P = 0.04). BAL KL-6 cut-off ≥ 72.32 U/ml and BAL CRP ≥ 14.55 mg/L predicted severe disease with area under the curve (AUC) values of 0.77 and 0.71, respectively. The combination of BAL neutrophilia, KL-6, and CRP predicted severity with an AUC value of 0.89. Conclusion The combination of BAL neutrophilia, KL-6, and CRP facilitates the severity stratification of CF-ILDs complementing existing severity parameters. Cureus 2023-07-19 /pmc/articles/PMC10439013/ /pubmed/37602059 http://dx.doi.org/10.7759/cureus.42162 Text en Copyright © 2023, Shadrach et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Pulmonology Shadrach, Benhur Joel Dutt, Naveen Elhence, Poonam Banerjee, Mithu Chauhan, Nishant Kumar Jalandra, Ram N Garg, Mahendra Kumar Garg, Pawan Tandon, Abhishek Shishir, Saumya Kochar, Rishabh Chhatwani, Bhavesh Pareek, Piyush Parrikar, Anika Clinical Utility of Bronchoalveolar Lavage Neutrophilia and Biomarkers for Evaluating Severity of Chronic Fibrosing Interstitial Lung Diseases |
title | Clinical Utility of Bronchoalveolar Lavage Neutrophilia and Biomarkers for Evaluating Severity of Chronic Fibrosing Interstitial Lung Diseases |
title_full | Clinical Utility of Bronchoalveolar Lavage Neutrophilia and Biomarkers for Evaluating Severity of Chronic Fibrosing Interstitial Lung Diseases |
title_fullStr | Clinical Utility of Bronchoalveolar Lavage Neutrophilia and Biomarkers for Evaluating Severity of Chronic Fibrosing Interstitial Lung Diseases |
title_full_unstemmed | Clinical Utility of Bronchoalveolar Lavage Neutrophilia and Biomarkers for Evaluating Severity of Chronic Fibrosing Interstitial Lung Diseases |
title_short | Clinical Utility of Bronchoalveolar Lavage Neutrophilia and Biomarkers for Evaluating Severity of Chronic Fibrosing Interstitial Lung Diseases |
title_sort | clinical utility of bronchoalveolar lavage neutrophilia and biomarkers for evaluating severity of chronic fibrosing interstitial lung diseases |
topic | Pulmonology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439013/ https://www.ncbi.nlm.nih.gov/pubmed/37602059 http://dx.doi.org/10.7759/cureus.42162 |
work_keys_str_mv | AT shadrachbenhurjoel clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases AT duttnaveen clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases AT elhencepoonam clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases AT banerjeemithu clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases AT chauhannishantkumar clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases AT jalandraramn clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases AT gargmahendrakumar clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases AT gargpawan clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases AT tandonabhishek clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases AT shishirsaumya clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases AT kocharrishabh clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases AT chhatwanibhavesh clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases AT pareekpiyush clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases AT parrikaranika clinicalutilityofbronchoalveolarlavageneutrophiliaandbiomarkersforevaluatingseverityofchronicfibrosinginterstitiallungdiseases |